{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:13:53Z","timestamp":1777605233259,"version":"3.51.4"},"reference-count":84,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Instituto de Salud Carlos III, Spain","award":["RICORS RD21\/0002\/0025"],"award-info":[{"award-number":["RICORS RD21\/0002\/0025"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Polymyalgia rheumatica (PMR) is an inflammatory disease common in people aged 50 years and older. This condition is characterized by the presence of pain and stiffness involving mainly the shoulder and pelvic girdle. Besides the frequent association with giant cell arteritis (GCA), several conditions may mimic PMR or present with PMR features. Since the diagnosis is basically clinical, an adequate diagnosis of this condition is usually required. Positron emission tomography\/computed tomography (PET-CT) has proved to be a useful tool for the diagnosis of PMR. The use of 18F-FDG-PET imaging appears promising as it provides detailed information on inflammatory activity that may not be evident with traditional methods. However, since PET-CT is not strictly necessary for the diagnosis of PMR, clinicians should consider several situations in which this imaging technique can be used in patients with suspected PMR.<\/jats:p>","DOI":"10.3390\/diagnostics14141539","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T08:48:29Z","timestamp":1721206109000},"page":"1539","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Positron Emission Tomography\/Computed Tomography in Polymyalgia Rheumatica: When and for What\u2014A Critical Review"],"prefix":"10.3390","volume":"14","author":[{"given":"Elena","family":"Heras-Recuero","sequence":"first","affiliation":[{"name":"Division of Rheumatology, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Bl\u00e1zquez-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Cristina","family":"Landaeta-Kancev","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mart\u00ednez de Bourio-Allona","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arantxa","family":"Torres-Rosell\u00f3","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Rengifo-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claritza","family":"Caraballo-Salazar","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-2944","authenticated-orcid":false,"given":"Raquel","family":"Largo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7748-853X","authenticated-orcid":false,"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de La Princesa, IIS-Princesa, 28006 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-7406","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040 Madrid, Spain"},{"name":"Medicine and Psychiatry Department, University of Cantabria, 39008 Santander, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Martin","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11926-014-0480-1","article-title":"Giant cell arteritis and polymyalgia rheumatica: An update","volume":"17","author":"Pina","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joim.13525","article-title":"An update on polymyalgia rheumatica","volume":"292","author":"Lundberg","year":"2022","journal-title":"J. Intern. Med."},{"key":"ref_4","first-page":"351","article-title":"High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community","volume":"9","author":"Noltorp","year":"1991","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/rheumatology\/34.3.261","article-title":"Epidemiology and mortality in 220 patients with polymyalgia rheumatica","volume":"34","author":"Schaufelberger","year":"1995","journal-title":"Br. J. Rheumatol."},{"key":"ref_6","first-page":"1739","article-title":"The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: A prospective study 1987\u20131994","volume":"24","author":"Gran","year":"1997","journal-title":"J. Rheumatol."},{"key":"ref_7","first-page":"1694","article-title":"Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA","volume":"29","author":"Doran","year":"2002","journal-title":"J. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semarthrit.2017.04.001","article-title":"Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015","volume":"47","author":"Crowson","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_9","first-page":"1326","article-title":"The spectrum of polymyalgia rheumatica in northwestern Spain: Incidence and analysis of variables associated with relapse in a 10 year study","volume":"26","author":"Dababneh","year":"1999","journal-title":"J. Rheumatol."},{"key":"ref_10","first-page":"205","article-title":"Polymyalgia rheumatica and giant cell arteritis: A 5-year epidemiologic and clinical study in Reggio Emilia, Italy","volume":"5","author":"Salvarani","year":"1987","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K","article-title":"Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms","volume":"43","author":"Mattey","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref_12","first-page":"2140","article-title":"Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association","volume":"25","author":"Dababneh","year":"1998","journal-title":"J. Rheumatol."},{"key":"ref_13","first-page":"S18","article-title":"Interferon-gamma gene mi-crosatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica","volume":"22","author":"Hajeer","year":"2004","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhao, S.S., Mackie, S.L., Larsson, S.C., Burgess, S., and Yuan, S. (2024). Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: Genome-wide meta-analysis and Mendelian randomisation. Rheumatology, keae308.","DOI":"10.1101\/2024.04.21.24306135"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"102732","DOI":"10.1016\/j.autrev.2020.102732","article-title":"Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review","volume":"20","author":"Liozon","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105150","DOI":"10.1016\/j.jbspin.2021.105150","article-title":"Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?","volume":"88","author":"Manzo","year":"2021","journal-title":"Jt. Bone Spine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","article-title":"Polymyalgia rheumatica","volume":"390","author":"Matteson","year":"2017","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(23)01310-7","article-title":"Polymyalgia rheumatica","volume":"402","author":"Dejaco","year":"2023","journal-title":"Lancet"},{"key":"ref_19","first-page":"755","article-title":"Polymyalgia manifestations in different conditions mimicking polymyalgia rheumatica","volume":"18","author":"Salvarani","year":"2000","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archinte.1997.00440240081012","article-title":"Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate: A more benign syndrome","volume":"157","author":"Blanco","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/art.1780390719","article-title":"Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment","volume":"39","author":"Meliconi","year":"1996","journal-title":"Arthritis Rheum."},{"key":"ref_22","first-page":"517","article-title":"Polymyalgia rheumatica: A disorder of extraarticular synovial structures?","volume":"26","author":"Salvarani","year":"1999","journal-title":"J. Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-127-1-199707010-00005","article-title":"Proximal bursitis in active polymyalgia rheumatica","volume":"127","author":"Salvarani","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"ref_24","first-page":"1049","article-title":"Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: A case-control study","volume":"28","author":"Cantini","year":"2001","journal-title":"J. Rheumatol."},{"key":"ref_25","first-page":"462","article-title":"Inflammatory changes of hip synovial structures in polymyalgia rheumatica","volume":"23","author":"Cantini","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/ard.2007.084723","article-title":"Cervical interspinous bursitis in active polymyalgia rheumatica","volume":"67","author":"Salvarani","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_27","first-page":"526","article-title":"Lumbar interspinous bursitis in active polymyalgia rheumatica","volume":"31","author":"Salvarani","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/ard.2008.087999","article-title":"The clinical implication of cervical interspinous bursitis inthe diagnosis of polymyalgia rheumatica","volume":"67","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.34356","article-title":"2012 Provisional classification criteria for polymyalgia rheumatica: A European League against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/annrheumdis-2013-204167","article-title":"Performance of the new 2012 EULAR\/ACR classification criteria for polymyalgia rheumatica: Comparison with the previous criteria in a single-centre study","volume":"73","author":"Macchioni","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_31","first-page":"1","article-title":"Ultrasound imaging for the rheumatologist XLIII. Ultrasonographic evaluation of shoulders and hips in patients with polymyalgia rheumatica: A systematic literature review","volume":"31","author":"Sakellariou","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cpet.2019.12.001","article-title":"Use of 18F-Fluorodeoxyglucose PET in the Diagnosis and Follow-up of Polymyalgia Rheumatica","volume":"15","author":"Betrains","year":"2020","journal-title":"PET Clin."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4081\/reumatismo.2018.1040","article-title":"Imaging in polymyalgia rheumatica","volume":"70","author":"Possemato","year":"2018","journal-title":"Reumatismo"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12149-018-1269-5","article-title":"Diagnosing polymyalgia rheumatica on 18F-FDG PET\/CT: Typical uptake patterns","volume":"32","author":"Yuge","year":"2018","journal-title":"Ann. Nucl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Gay, M.\u00c1., Heras-Recuero, E., Bl\u00e1zquez-S\u00e1nchez, T., Caraballo-Salazar, C., Rengifo-Garc\u00eda, F., Casta\u00f1eda, S., and Largo, R. (Expert. Rev. Clin. Immunol., 2024). Broadening the clinical spectrum of giant cell arteritis: From the classic cranial to the predominantly extracranial pattern of the disease, Expert. Rev. Clin. Immunol., epub ahead of print.","DOI":"10.1080\/1744666X.2024.2356741"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.semnuclmed.2022.08.010","article-title":"Update on Imaging of In-flammatory Arthritis and Related Disorders","volume":"53","author":"Jamar","year":"2023","journal-title":"Semin. Nucl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00296-023-05284-8","article-title":"Imaging methods in polymyalgia rheumatica: A systematic review","volume":"43","author":"Mekenyan","year":"2023","journal-title":"Rheumatol. Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"rkae003","DOI":"10.1093\/rap\/rkae003","article-title":"Characterising polymyalgia rheumatica on whole-body 18F-FDG PET\/CT: An atlas","volume":"8","author":"Owen","year":"2024","journal-title":"Rheumatol. Adv. Pract."},{"key":"ref_39","first-page":"2179","article-title":"The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain","volume":"27","author":"Salvarani","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/03009742.2023.2215044","article-title":"Differential diagnostics of polymyalgia rheumatica in a university hospital in Finland","volume":"52","author":"Paltta","year":"2023","journal-title":"Scand. J. Rheumatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.semnuclmed.2023.10.003","article-title":"[18F]FDG-PET\/CT in Polymyalgia Rheumatica: An Update and Future Aspects","volume":"54","author":"Gheysens","year":"2023","journal-title":"Semin. Nucl. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s00259-020-05162-6","article-title":"Diagnostic value of [18F]FDG-PET\/CT in polymyalgia rheumatica: A systematic review and meta-analysis","volume":"48","author":"Treglia","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.55563\/clinexprheumatol\/4r78yg","article-title":"Clinical and FDG-PET\/CT correlates in patients with polymyalgia rheumatica","volume":"40","author":"Camellino","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/MNM.0000000000001292","article-title":"Diagnostic performance of F-18 fluorodeoxyglucose PET\/computed tomography for diagnosis of polymyalgia rheumatica: A meta-analysis","volume":"41","author":"Kim","year":"2020","journal-title":"Nucl. Med. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Amat, J., Chanchou, M., Olagne, L., Descamps, L., Flaus, A., Bouvet, C., Barres, B., Valla, C., Molnar, L., and Cougoul, A. (2020). Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography in Inflammatory Rheumatism, Particularly Polymyalgia Rheumatica: A Retrospective Study of 222 PET\/CT. Front. Med., 7.","DOI":"10.3389\/fmed.2020.00394"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Moreel, L., Boeckxstaens, L., Betrains, A., Van Hemelen, M., Vanderschueren, S., Van Laere, K., and Blockmans, D. (2022). Diagnostic accuracy and validation of 18F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica. Front. Med., 9.","DOI":"10.3389\/fmed.2022.1026944"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/keab483","article-title":"Comparison and validation of FDG-PET\/CT scores for polymyalgia rheumatica","volume":"61","author":"Nienhuis","year":"2022","journal-title":"Rheumatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/rheumatology\/kew202","article-title":"Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: A controlled study","volume":"55","author":"Sondag","year":"2016","journal-title":"Rheumatology"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Flaus, A., Amat, J., Prevot, N., Olagne, L., Descamps, L., Bouvet, C., Barres, B., Valla, C., Mathieu, S., and Andre, M. (2021). Decision Tree with Only Two Musculoskeletal Sites to Diagnose Polymyalgia Rheumatica Using [18F]FDG PET-CT. Front. Med., 8.","DOI":"10.3389\/fmed.2021.646974"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00259-020-04731-z","article-title":"Abnormalities at three musculoskeletal sites on whole-body positron emission tomography\/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity","volume":"47","author":"Owen","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Brinth, L.S., Hansen, A., Jensen, D.V., Madsen, O.R., Broholm, R., and Krakauer, M. (2023). Diagnostic Value of Composite and Simplified FDG-PET\/CT Scores in Polymyalgia Rheumatica and the Influence of Recent Glucocorticoid Treatment\u2014A Retrospective Diagnostic Cohort Study. Diagnostics, 13.","DOI":"10.3390\/diagnostics13030514"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/mr\/road051","article-title":"Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography and computed tomography for differentiating polymyalgia rheumatica and rheumatoid arthritis: Using classification and regression tree analysis","volume":"34","author":"Ikuma","year":"2024","journal-title":"Mod. Rheumatol."},{"key":"ref_53","first-page":"1456","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography in polymyalgia rheumatica: An observational study","volume":"41","author":"Benali","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/rheumatology\/kex376","article-title":"Use of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica\u2014A prospective study of 99 patients","volume":"57","author":"Henckaerts","year":"2018","journal-title":"Rheumatology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/s10165-011-0581-x","article-title":"Whole-body fluorodeoxyglucose positron emission tomography\/computed tomography in patients with active polymyalgia rheumatica: Evidence for distinctive bursitis and large-vessel vasculitis","volume":"22","author":"Yamashita","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Heras-Recuero, E., Landaeta-Kancev, L.C., de Bourio-Allona, M.M., Torres-Rosello, A., Bl\u00e1zquez-S\u00e1nchez, T., Ferraz-Amaro, I., Casta\u00f1eda, S., Mart\u00ednez-L\u00f3pez, J.A., Mart\u00ednez-Dhier, L., and Largo, R. (2023). Positron Emission Computed Tomography Spectrum of Large Vessel Vasculitis in a Tertiary Center: Differences in 18F-fluorodeoxyglucose Uptake between Large Vessel Vasculitis with Predominant Cranial and Extracranial Giant Cell Arteritis Phenotypes. J. Clin. Med., 12.","DOI":"10.3390\/jcm12196164"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Heras-Recuero, E., de Bourio-Allona, M.M., Landaeta-Kancev, L.C., Bl\u00e1zquez-S\u00e1nchez, T., Torres-Rosell\u00f3, A., \u00c1lvarez-Rubio, M., Belhaj-Gandar, M., Mart\u00ednez-L\u00f3pez, J.A., Mart\u00ednez-Dhier, L., and Llorca, J. (2023). 18F-Fluorodeoxyglucose Positron Emission Tomography\u2013Computed Tomography Findings of Polymyalgia Rheumatica in Patients with Giant Cell Arteritis. J. Clin. Med., 12.","DOI":"10.20944\/preprints202310.0554.v1"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2967\/jnumed.122.265016","article-title":"Role of 18F-FDG PET\/CT in Large Vessel Vasculitis and Polymyalgia Rheumatica","volume":"64","author":"Slart","year":"2023","journal-title":"J. Nucl. Med."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Gorlen, T.F., Brittain, J.M., \u00d8stergaard, M., Fischer, B.M., D\u00f8hn, U.M., and Terslev, L. (2024). Low incidence of malignancy in patients with suspected polymyalgia rheumatica or giant cell arteritis, examined with FDG-PET\/CT. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1309905"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Abdel-Wahab, N., and Suarez-Almazor, M.E. (2024). Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy. Expert Rev. Clin. Immunol., 1\u201321.","DOI":"10.1080\/1744666X.2024.2323966"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.rdc.2024.02.001","article-title":"Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica","volume":"50","author":"Liew","year":"2024","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Vermeulen, O.C.B., Brouwer, E., Slart, R.H.J.A., Sandovici, M., Rutgers, A., Hilterman, T.J., Hiddinga, B., Oosting, S.F., Jalving, M., and de Heij, A.H. (2024). Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: Comparison of disease characteristics and treatment requirement. Rheumatology, keae099.","DOI":"10.1093\/rheumatology\/keae099"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Desvages, A., Hives, F., Deprez, X., Pierache, A., B\u00e9hal, H., Flipo, R.-M., and Paccou, J. (2023). Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in Diagnosing Polymyalgia Rheumatica and Large-Vessel Vasculitis: A Case-Control Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12082844"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"iii5","DOI":"10.1093\/rheumatology\/kez553","article-title":"Diagnosis of giant cell arteritis","volume":"59","author":"Ponte","year":"2020","journal-title":"Rheumatology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ccl.2023.01.012","article-title":"Positron Emission Tomography Imaging in Vasculitis","volume":"41","author":"Slijkhuis","year":"2023","journal-title":"Cardiol. Clin."},{"key":"ref_66","first-page":"S138","article-title":"Isolated vasculitis of the lower extremities in a patient with polymyalgia rheumatica and giant cell arteritis","volume":"29","author":"Versari","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ard-2023-224543","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","volume":"83","author":"Dejaco","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.semarthrit.2018.05.007","article-title":"Predictors of positive 18F-FDG PET\/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica","volume":"48","author":"Loricera","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"20170198","DOI":"10.1259\/bjr.20170198","article-title":"18F-FDG PET\/CT in polymyalgia rheumatica\u2014A pictorial review","volume":"90","author":"Rehak","year":"2017","journal-title":"Br. J. Radiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.semnuclmed.2017.02.005","article-title":"Clinical Value of FDG-PET\/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis","volume":"47","author":"Kubota","year":"2017","journal-title":"Semin. Nucl. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"105325","DOI":"10.1016\/j.jbspin.2021.105325","article-title":"Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice","volume":"89","author":"Besson","year":"2022","journal-title":"Jt. Bone Spine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e7297","DOI":"10.1097\/MD.0000000000007297","article-title":"Polymyalgia rheumatica and giant cell arteritis\u2014Three challenges\u2014Consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol","volume":"96","author":"Emamifar","year":"2017","journal-title":"Medicine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e1542","DOI":"10.1097\/MD.0000000000001542","article-title":"Different Scoring Methods of FDG PET\/CT in Giant Cell Arteritis: Need for Standardization","volume":"94","author":"Stellingwerff","year":"2015","journal-title":"Medicine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","article-title":"Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy","volume":"45","author":"Nielsen","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s00259-024-06697-8","article-title":"The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET\/CT in polymyalgia rheumatica\u2014A prospective study of 101 patients","volume":"51","author":"Nielsen","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: A prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","journal-title":"Rheumatology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/rheumatology\/keq450","article-title":"Imaging of polymyalgia rheumatica: Indications on its pathogenesis, diagnosis and prognosis","volume":"51","author":"Camellino","year":"2012","journal-title":"Rheumatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: A European League against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/acr2.11163","article-title":"The Utility of 18F-FDG PET\/CT in Patients with Clinical Suspicion of Polymyalgia Rheumatica and Giant Cell Arteritis: A Prospective, Observational, and Cross-sectional Study","volume":"2","author":"Emamifar","year":"2020","journal-title":"ACR Open Rheumatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"103415","DOI":"10.1016\/j.autrev.2023.103415","article-title":"Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?","volume":"23","author":"Salvarani","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1093\/rheumatology\/keac125","article-title":"The role of PET\/CT in disease activity assessment in patients with large vessel vasculitis","volume":"61","author":"Galli","year":"2022","journal-title":"Rheumatology"},{"key":"ref_82","first-page":"63","article-title":"Decoding poly-myalgia rheumatica, the role of Nuclear Medicine Imaging","volume":"43","year":"2024","journal-title":"Rev. Esp. Med. Nucl. Imagen. Mol. (Engl. Ed.)"},{"key":"ref_83","unstructured":"Garc\u00eda, A.G., Fabregate, M., Serralta, G., de Miguel Campo, B., Mozo, A.N., and Robles-Marhuenda, \u00c1. The utility of 18F-FDG-PET\/CT in detecting extracranial large vessel vasculitis in rheumatic polymyalgia or giant cell arteritis: A systematic review and meta-analysis, Rev. Clin. Esp., in press."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/rheumatology\/kex478","article-title":"In search of a diagnostic test for polymyalgia rheumatica: Is positron emission tomography the answer?","volume":"57","author":"Clifford","year":"2018","journal-title":"Rheumatology"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/14\/1539\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:18:11Z","timestamp":1760109491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/14\/1539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":84,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["diagnostics14141539"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14141539","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]}}}